Single-vesicle tracking reveals the potential correlation of the movement of cell-bound membrane vesicles (CBMVs) with cell migration

Biochim Biophys Acta Mol Cell Res. 2020 Nov;1867(11):118804. doi: 10.1016/j.bbamcr.2020.118804. Epub 2020 Jul 30.

Abstract

The movement of cell-bound membrane vesicles (CBMVs) on migrating cells is poorly understood. We hypothesized that the movement of CBMVs on migrating cells is different from that on non-migrating cells and can be interfered by external stimuli. To test it, single-vesicle tracking was performed to analyze motion type, speed, displacement, and direction of CBMVs on migrating cells treated with different reagents (Ang-1, TNF-α, LPS, VEGFα, endostatin, Cytochalasin D, and nocodazole) among which the former four promoted cell migration whereas the others inhibited cell migration. We found that cell migration changed CBMVs from non-directed to directed motion and that most CBMVs on untreated migrating cells moved along the migration axis. Interestingly, the migration-promoting reagents played positive roles in CBMV movement (improving directed motion, speed and/or maximal displacement, upregulating the amount of vesicles moving in migration direction) whereas the migration-inhibiting reagents played negative roles (impairing/abolishing directed motion, speed and/or maximal displacement, downregulating the vesicles moving forward or causing an even distribution of motion direction). The cytoskeleton (particularly microtubules) probably played vital roles in CBMV movement on migrating cells and mediated the effects of stimuli on vesicle movement. The data may provide important information for understanding the properties, behaviors, and functions of CBMVs.

Keywords: Cell migration; Cell-bound membrane vesicles (CBMVs); Cytoskeleton; Human umbilical vein endothelial cells (HUVECs); Single-vesicle tracking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / pharmacology
  • Cell Membrane / drug effects
  • Cell Membrane / genetics*
  • Cell Membrane / metabolism
  • Cell Movement / drug effects
  • Cell Movement / genetics*
  • Cytochalasin D / pharmacology
  • Cytoskeleton / drug effects*
  • Cytoskeleton / genetics
  • Endostatins / pharmacology
  • Humans
  • Microtubules / drug effects
  • Microtubules / genetics*
  • Nocodazole / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • Endostatins
  • Tumor Necrosis Factor-alpha
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Cytochalasin D
  • Angiotensin I
  • Nocodazole